今日盘中，药明康德（02359.HK）股价大跌5.27%，引发市场广泛关注。股价下跌主要源于公司宣布的一项大规模配股计划。
根据公司公告，药明康德计划配售7,380万股新H股，配售价为每股104.27港元，较最新收盘价112港元折让约6.9%。假设所有配售股份获悉数认购，此次配售预计将为公司募集约77亿港元（净额约76.5亿港元）的资金。
配售股份数量占扩大后已发行H股总数及已发行股份总数的约16.01%及2.51%。公司表示，募集资金的使用计划如下：约90%将用于加速推进全球布局和产能建设，剩余约10%将用于补充一般运营资金。
尽管此次融资将为药明康德的全球扩张战略提供强有力的资金支持，但新股发行对现有股东权益的稀释效应以及折价发行可能是导致股价下跌的主要原因。投资者可能需要关注公司后续的资金使用效率及全球扩张计划的执行情况，以评估此次融资对公司长期发展的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.